0001140361-23-029893.txt : 20230614
0001140361-23-029893.hdr.sgml : 20230614
20230614182750
ACCESSION NUMBER: 0001140361-23-029893
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230613
FILED AS OF DATE: 20230614
DATE AS OF CHANGE: 20230614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sveen David E.
CENTRAL INDEX KEY: 0001592387
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22427
FILM NUMBER: 231015469
MAIL ADDRESS:
STREET 1: 3760 ROCKY MOUNTAIN AVENUE
CITY: LOVELAND
STATE: CO
ZIP: 80538
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HESKA CORP
CENTRAL INDEX KEY: 0001038133
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 770192527
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3760 ROCKY MOUNTAIN AVENUE
CITY: LOVELAND
STATE: CO
ZIP: 80538
BUSINESS PHONE: 9704937272
MAIL ADDRESS:
STREET 1: 3760 ROCKY MOUNTAIN AVENUE
CITY: LOVELAND
STATE: CO
ZIP: 80538
4
1
form4.xml
X0407
4
2023-06-13
true
0001038133
HESKA CORP
HSKA
0001592387
Sveen David E.
3760 ROCKY MOUNTAIN AVENUE
LOVELAND
CO
80538
true
false
Common Stock
2023-06-13
4
D
0
21653
120
D
0
D
Common Stock
2023-06-13
4
D
0
14285
120
D
0
I
by Bethany Creek
Common Stock
2023-06-13
4
D
0
7143
120
D
0
I
by Lindberg Capital
Disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 31, 2023, by and among the Issuer, Antech Diagnostics, Inc., a California corporation ("Acquiror"), Helsinki Merger Sub LLC, a Delaware limited liability company and a wholly-owned subsidiary of Acquiror, and, solely for purposes of Section 9.15 of the Merger Agreement, Mars, Incorporated, a Delaware corporation, in exchange for cash consideration of $120.00 per share of common stock of the Issuer on the effective date of the merger.
Represents shares held by Bethany Creek Partners, LP. Dr. Sveen is a general partner of and an investor in Bethany Creek Partners, LP.
Represents shares held by Lindberg Capital Partners, LP. Dr. Sveen is a general partner of and an investor in Lindberg Capital Partners, LP.
/s/ By: Catherine Grassman For: David E. Sveen
2023-06-13